Anna Krasinski's questions to Quest Diagnostics Inc (DGX) leadership • Q2 2025
Question
Anna Krasinski, on for Luke Sergott at Barclays, asked about the drivers behind the significant step-up in organic volume growth this quarter compared to the prior year's trend and how to think about this metric going forward.
Answer
CEO James Davis attributed the strong organic volume growth to several factors: a steady ramp-up in business from new health plan access gained in January, strong uptake in advanced diagnostics, and a rebound from weather-impacted appointments in Q1. He also noted that the employer health and drug testing businesses have stabilized and are no longer a headwind. CFO Sam Samad added that increased requisition density (tests per req) also contributed to strong overall results.